Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Liberal states begin stockpiling abortion medications following Texas court ruling

April 12, 2023 Medical Communications

Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following a Texas judge Matthew Kacsmaryk’s attempt …
News
carlos-muza-hpjsku2uysu-unsplash_1

Cognizant and Boehringer Ingelheim collaborate on integrated cloud platform to improve therapy development

April 12, 2023 Medical Communications

US-based Cognizant and biopharmaceutical company Boehringer Ingelheim have announced a partnership to collaborate on ensuring the quality, and increasing the …
News

FDA authorises marketing of MISHA Knee System for patients with knee osteoarthritis

April 11, 2023 Medical Communications

Medical device company, Moximed, has announced that the FDA granted marketing authorisation of its MISHA Knee System, an implantable shock …
News
christina-victoria-craft-whsnkiwwpec-unsplash_4

AstraZeneca’s Lynparza approved by NHS England

April 6, 2023 Medical Communications

NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …
News

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

April 5, 2023 Medical Communications

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …
News
hal-gatewood-ipl3q-gegzy-unsplash_2

FDA requires prepaid mail-back envelopes for opioid analgesics

April 5, 2023 Medical Communications

The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …
News
towfiqu-barbhuiya-6f2mpewg2ra-unsplash

FDA publishes report stating Global Pharma’s eye drops broke safety norms

April 4, 2023 Medical Communications

The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms …
News
james-yarema-5tymgag0wro-unsplash_1

InnoCare announced first subject dosed in clinical trial of novel targeted protein degrader ICP-490

April 4, 2023 Medical Communications

InnoCare has announced that the first subject has been dosed in its clinical trial of its novel targeted protein degrader …
News

Merck receives FDA approval for Keytruda in combination with Padcev to treat bladder cancer

April 4, 2023 Medical Communications

Merck (known as MSD globally) has announced that it has received FDA approval for Keytruda in combination with Padcev for …
News
david-travis-avvzjc0ynbq-unsplash_1

Pixium Vision’s Prima System granted FDA Breakthrough Device Designation

April 3, 2023 Medical Communications

French bioelectronics company Pixium Vision has been granted Breakthrough Device Designation by the FDA for its Prima System.   Prima …
News
pawel-czerwinski-kxblpqfyc9e-unsplash

AstraZeneca’s NMOSD treatment recommended marketing authorisation by CHMP

April 3, 2023 Medical Communications

Pharma giant AstraZeneca has been given a recommendation by the EU’s Committee for Medicinal Products (CHMP) for marketing authorisation for …
News

Abbott gains FDA approval for Epic Max tissue valve for the treatment of aortic valve disease

March 31, 2023 Medical Communications

Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation …
News

First over-the-counter opioid overdose treatment approved by FDA

March 31, 2023 Medical Communications

The FDA has announced that it has approve Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use. This …
News

NEC streamlines AI drug development with subsidiary reshuffle

March 31, 2023 Medical Communications

Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. …
News

Nanoscope Therapeutics announces positive results from phase 2b trial in Retinitis Pigmentosa

March 31, 2023 Medical Communications

US-based Nanoscope Therapeutics has announced topline results from its phase 2b RESTORE clinical trial. Currently, patients with vision loss due …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026